HIV vaccine partnerships offer hope to the developing worldBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7172.1543 (Published 05 December 1998) Cite this as: BMJ 1998;317:1543
- Hugh Matthews
Two research programmes into a vaccine for HIV, costing £5.6m ($9m) and involving partnerships between British, American, and African researchers, were launched last week. They aim to produce a vaccine for the virus which is effective against the strains prevalent in the developing world and affordable to the governments of the worst affected countries.
Launching the new projects, Dr Seth Berkley, the president of the International AIDS Vaccine Initiative, a scientific organisation set up to find an AIDS vaccine, said: “Only a vaccine has …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial